Unicancer
Audrey ACLOQUE is a data protection officer at Unicancer since June 2020, where responsibilities include developing and managing data protection policies, regulatory compliance monitoring, government agency liaison, and oversight of high-profile projects within the healthcare framework. Prior experience includes serving as a juriste NTIC-project manager GDPR at Etablissement Francais du Sang, focusing on GDPR compliance and project analysis. Additional roles include positions at LLC ET ASSOCIES, groupe ADSN, Ceva sante animale, and various law firms, encompassing areas such as intellectual property, data protection audits, legal consultation, and family law. Audrey ACLOQUE holds a Master 2 in industrial property and health industry law from Université Paris 8, along with prior degrees in private law from Université Paris-Est Créteil.
This person is not in the org chart
This person is not in any teams
Unicancer
UNICANCER groups together the 20 French Comprehensive Cancer Centres (FCCCs) which are private, not-for-profit hospitals located across the French territory. FCCCs are dedicated to fighting cancer through a threefold mission of patient care, research and education. They contribute to the public hospital service in accordance with statutory fees, with no additional charge. UNICANCER is one of the largest cancer care and research organisations in Europe. Via its R&D department, it sponsors clinical trials to improve cancer patients’ care and access to innovation, particularly in areas neglected by the pharmaceutical industry. UNICANCER is accredited by the French Ministry of Health and is eligible for public grants. The French Comprehensive Cancer Centres in numbers: • 20 sites located throughout the French territory • 19,000 employees • >135,000 patients hospitalised each year • Approximately 500 active clinical trials • 17% of the patients treated are included in a clinical trial (vs an average of 8.5% of cancer patients in France) • 19 molecular biology platforms certified by the French National Cancer Institute • 7 integrated cancerology research sites (SIRIC) certified by the French NCI (out of 8) • 12 early-phase clinical trial Centres (CLIP²) certified by the French NCI (out of 16) • 5th for global publications in oncology • 32% of French publications in oncology (articles in which FCCCs have participated) UNICANCER sponsors • 76 ongoing clinical trials (2016) • Including 5400 patients (2016) • From 270 investigator sites (2015), • With 20% located in other European countries